Ir al contenido principal

Vasodilatadores periféricos

Los vasodilatadores periféricos son medicamentos que se utilizan para tratar afecciones que afectan los vasos sanguíneos en las partes externas (periféricas) del cuerpo, como los brazos y las piernas. Por ejemplo, se usan para tratar la enfermedad arterial periférica y el fenómeno de Raynaud. Alivian los síntomas de estas condiciones al dilatar los vasos sanguíneos, evitando que se estrechen (constricción). Estos medicamentos generalmente solo se recetan después de haber probado medidas de autoayuda y no haber mejorado los síntomas.

verificador de síntomas

¿Inseguro sobre mezclar medicamentos?

Verifica posibles interacciones entre medicamentos, suplementos y alimentos antes de tomarlos juntos.

Video picks for Medicamentos para el corazón y la sangre

Continúa leyendo abajo

What are peripheral vasodilators?

Peripheral vasodilators are used in peripheral arterial disease (PAD) and intermittent claudication to try to open up (dilate) the arteries; this helps to increase the distance you can walk before pain develops.

In el fenómeno de Raynaud they are used to dilate the small blood vessels and prevent them from constricting. This helps to maintain the blood supply to the fingers, etc.

The peripheral vasodilator medications all reduce 'vascular resistance'. This is the resistance that should be overcome to push blood through the vessels in the limbs, to allow blood to flow.

There are a number of different peripheral vasodilator drugs. They include, nifedipine, cilostazol, moxisylyte, naftidrofuryl and pentoxifylline. These medicines are available as tablets and capsules and each one may have various other brand names (see Generic Medicines vs Brand Names).

Inositol nicotinate and pentoxifylline are not considered effective for PAD. Pentoxifylline and moxisylyte are not considered effective for Raynaud's phenomenon.

In cases of intermittent claudication, a vasodilator is usually only prescribed if self-help measures such as exercise have not improved the symptoms and surgery is not being considered.

However, they do not work in all cases. Therefore, there is no point in continuing with these medicines if an improvement in symptoms is not seen within a few weeks. If symptoms do not improve, stopping treatment would usually be advised. If symptoms improve, the treatment can be continued. The treatment is usually reviewed regularly to ensure that it is still being of benefit.

In Raynaud's phenomenon, nifedipine is usually only prescribed after self-help measures (such as keeping the whole body warm, including the hands and feet, and stopping smoking) have been tried and the symptoms have not improved. Usually a short course of nifedipine is prescribed to begin with to see if it works..

Continúa leyendo abajo

Peripheral vasodilators work in slightly different ways to one another.

  • Cilostazol and inositol nicotinate work by widening the arteries that supply blood to the legs. Cilostazol also improves circulation by keeping platelets in the blood from sticking together and clotting.

  • Naftidrofuryl works by blocking the effects of a chemical called serotonin on the blood vessels. As a serotonin receptor blocker, Naftidrofuryl widens blood vessels to improve blood flow and also by allowing the body to make better use of oxygen available in the blood.

  • Nifedipine is a type of medicine called a calcium-channel blocker. It is sometimes used to treat high blood pressure but it is also a peripheral vasodilator. It works by widening the blood vessels and stopping them from going into a spasm or narrowing.

  • Moxisylyte is a type of medicine called an alpha-blocker. It works by relaxing the blood vessels, which in turn maintains the supply of blood to the fingers, toes, ears or nose.

  • Pentoxifylline works by decreasing the thickness of the blood. Blood is then able to flow more easily, especially in the small blood vessels of the hands and feet.

Peripheral arterial disease (PAD):

national guidelines only recommend the use of naftidrofuryl for people with intermittent claudication caused by PAD. Other peripheral vasodilators are not normally prescribed because there is little evidence that any of the others work very well for this condition. However, cilostazol can sometimes be used for the treatment of PAD in selected patients who do not respond to other treatments.

Raynaud's phenomenon:

Nifedipine is recommended to reduce the number and severity of 'vasospastic' attacks - when the blood vessels become narrow (constrict). Other peripheral vasodilators are not normally prescribed, as there is not much evidence to show that they work very well for Raynaud's phenomenon.

Sometimes, if the side-effects of nifedipine cannot be tolerated, a doctor may consider prescribing a different bloqueador de los canales de calcio such as nicardipine, amlodipina o felodipine. These medicines are not licensed to treat Raynaud's disease. Rarely, naftidrofuryl or inositol nicotinate may also be prescribed by some doctors to treat Raynaud's phenomenon.

Continúa leyendo abajo

How nifedipina is taken will depend upon the pattern of symptoms and how well symptoms improve with treatment.

All other vasodilators are taken every day.

Most people who take peripheral vasodilators have no side-effects, or only minor ones. It is not possible in this leaflet to list all the possible side-effects of these medicines. For more detailed information, see the leaflet that comes within the medicine packet.

Nifedipine - some people develop flushing and dolor de cabeza. Serious side-effects are rare.

Naftidrofuryl - the most commonly reported side-effects are feeling sick, skin rash, stomach pains and runny stools (diarrea). On rare occasions, some people taking naftidrofuryl have developed a liver disorder. If any yellowing of the skin or the whites of the eyes is seen, speak with a doctor straightaway.

Cilostazol - the most common side-effects include headache and diarrhoea. Less common side-effects include mareos, weakness, feeling or being sick, indigestión, tummy (abdominal) pain, fast heartbeat, chest pain, runny nose, bruising, swollen ankles or feet, skin rash and itching.

Inositol nicotinate - side-effects are thought to be uncommon but may include flushing, dizziness, headache, feeling sick, being sick (vomiting), fainting and a rash.

Moxisylyte - the most common side-effects include mild náuseas, diarrhoea, dizziness with a spinning sensation (vértigo), headache, facial flushing and a rash. On rare occasions, some people taking moxisylyte have developed a liver disorder. If any yellowing of the skin or the whites of the eyes is seen, speak with a doctor straightaway.

Pentoxifylline - the most common side-effects include nausea, vomiting, and dizziness which may occur. Uncommonly, some people experience a fast or irregular heartbeat.

Drinking grapefruit juice can interact with nifedipine and alter its effect. Therefore, grapefruit juice should be avoided by anyone taking this particular vasodilator.

No, you cannot buy oral peripheral vasodilators; you need a prescription to obtain these medicines.

Most people are able to take a peripheral vasodilator; however, in some cases these medicines are best avoided.

Nifedipine - should not be given to people who:

  • Have severe damage to the heart muscle (cardiogenic shock).

  • Have a valve in the heart that does not open fully (advanced aortic stenosis).

  • Are within one month of having had a ataque al corazón.

  • Have acute attacks of angina.

Naftidrofuryl - should not be given to people with a history of cálculos renales.

Cilostazol - should not be given to people with:

Inositol nicotinate - should not be given to people who have had a recent heart attack (myocardial infarction) or stroke.

Moxisylyte - is safe to use in most people.

Pentoxifylline - should not be given to people who have had:

  • Un derrame cerebral.

  • Extensive back of the eye (retinal) bleeding.

  • A heart attack.

  • Heart rhythm problems.

For more detailed information, see the leaflet that comes with the medicine packet.

Patient picks for Medicamentos para el corazón y la sangre

Aspirina y otros medicamentos antiplaquetarios

Tratamiento y medicación

Aspirina y otros medicamentos antiplaquetarios

La mayoría de las personas que tienen una enfermedad cardiovascular (por ejemplo, angina, enfermedad arterial periférica, o un ataque al corazón previo, ataque isquémico transitorio (AIT) o accidente cerebrovascular) toman una aspirina de baja dosis (75 mg) cada día o clopidogrel (75 mg) cada día. Esto reduce el riesgo de ataque al corazón en aproximadamente un tercio. Reduce el riesgo de tener un accidente cerebrovascular en aproximadamente un cuarto. Una dosis baja diaria de aspirina también reduce el riesgo de desarrollar varios tipos de cáncer comunes, pero no se aconseja que toda la población tome aspirina por esta razón. Esto se debe a que en algunas personas la aspirina puede aumentar el riesgo de sangrado estomacal y úlceras estomacales, que a veces son fatales.

por la Dra. Toni Hazell, MRCGP

Medicamentos con nitratos

Tratamiento y medicación

Medicamentos con nitratos

Los medicamentos con nitratos incluyen trinitrato de glicerilo (GTN), dinitrato de isosorbida y mononitrato de isosorbida. Cada uno tiene varias marcas comerciales. Los medicamentos con nitratos no modifican la causa subyacente de la angina. (La angina generalmente es causada por el estrechamiento de las arterias del corazón debido a una acumulación de una sustancia grasa llamada ateroma. Consulte el folleto separado llamado Angina.) Sin embargo, los medicamentos con nitratos son eficaces para aliviar y prevenir los dolores de angina.

by Dr Hayley Willacy, FRCGP

verificador de síntomas

¿Inseguro sobre mezclar medicamentos?

Verifica posibles interacciones entre medicamentos, suplementos y alimentos antes de tomarlos juntos.

Lecturas adicionales y referencias

  • Lower limb peripheral arterial disease; NICE Clinical Guideline (August 2012, updated December 2020)
  • Aboyans V, Ricco JB, Bartelink MEL, et al; 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2017 Aug 26. doi: 10.1093/eurheartj/ehx095.
  • Su KY, Sharma M, Kim HJ, et al; Vasodilators for primary Raynaud's phenomenon. Cochrane Database Syst Rev. 2021 May 17;5:CD006687. doi: 10.1002/14651858.CD006687.pub4.
  • el fenómeno de Raynaud; NICE CKS, November 2022 (UK access only)
  • Enfermedad Arterial Periférica; NICE CKS, marzo 2024 (acceso solo en el Reino Unido)
  • Golledge J, Drovandi A; Evidence-Based Recommendations for Medical Management of Peripheral Artery Disease. J Atheroscler Thromb. 2021 Jun 1;28(6):573-583. doi: 10.5551/jat.62778. Epub 2021 Mar 21.

Continúa leyendo abajo

Historial del artículo

La información en esta página está escrita y revisada por pares por clínicos calificados.

  • Próxima revisión: 26 de septiembre de 2028
  • 28 Sept 2023 | Última versión

    Última actualización por

    Dra. Surangi Mendis, MRCGP

    Revisado por pares por

    Dra. Philippa Vincent, MRCGP
verificador de elegibilidad para la gripe

Pregunta, comparte, conecta.

Navega por discusiones, haz preguntas y comparte experiencias en cientos de temas de salud.

verificador de síntomas

¿Te sientes mal?

Evalúa tus síntomas en línea de forma gratuita

Suscríbete al boletín de Patient

Tu dosis semanal de consejos de salud claros y confiables, escritos para ayudarte a sentirte informado, seguro y en control.

Por favor, introduce una dirección de correo electrónico válida

By subscribing you accept our Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.